Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2009 2
2010 2
2011 3
2012 2
2013 3
2014 6
2015 6
2016 5
2017 2
2018 3
2019 4
2020 3
2021 4
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
Zhang SM, Cai WL, Liu X, Thakral D, Luo J, Chan LH, McGeary MK, Song E, Blenman KRM, Micevic G, Jessel S, Zhang Y, Yin M, Booth CJ, Jilaveanu LB, Damsky W, Sznol M, Kluger HM, Iwasaki A, Bosenberg MW, Yan Q. Zhang SM, et al. Among authors: jilaveanu lb. Nature. 2021 Oct;598(7882):682-687. doi: 10.1038/s41586-021-03994-2. Epub 2021 Oct 20. Nature. 2021. PMID: 34671158 Free PMC article.
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
Djureinovic D, Weiss SA, Krykbaeva I, Qu R, Vathiotis I, Moutafi M, Zhang L, Perdigoto AL, Wei W, Anderson G, Damsky W, Hurwitz M, Johnson B, Schoenfeld D, Mahajan A, Hsu F, Miller-Jensen K, Kluger Y, Sznol M, Kaech SM, Bosenberg M, Jilaveanu LB, Kluger HM. Djureinovic D, et al. Among authors: jilaveanu lb. Mol Cancer. 2023 Nov 14;22(1):182. doi: 10.1186/s12943-023-01884-x. Mol Cancer. 2023. PMID: 37964379 Free PMC article.
Complications associated with immunotherapy for brain metastases.
Tran TT, Jilaveanu LB, Omuro A, Chiang VL, Huttner A, Kluger HM. Tran TT, et al. Among authors: jilaveanu lb. Curr Opin Neurol. 2019 Dec;32(6):907-916. doi: 10.1097/WCO.0000000000000756. Curr Opin Neurol. 2019. PMID: 31577604 Free PMC article. Review.
CEACAM1: Expression and Role in Melanocyte Transformation.
Turcu G, Nedelcu RI, Ion DA, Brînzea A, Cioplea MD, Jilaveanu LB, Zurac SA. Turcu G, et al. Among authors: jilaveanu lb. Dis Markers. 2016;2016:9406319. doi: 10.1155/2016/9406319. Epub 2016 Aug 24. Dis Markers. 2016. PMID: 27642217 Free PMC article. Review.
Studies of NVP-BEZ235 in melanoma.
Sznol JA, Jilaveanu LB, Kluger HM. Sznol JA, et al. Among authors: jilaveanu lb. Curr Cancer Drug Targets. 2013 Feb;13(2):165-74. doi: 10.2174/1568009611313020006. Curr Cancer Drug Targets. 2013. PMID: 23215722 Review.
Advances in therapy for melanoma brain metastases.
Flanigan JC, Jilaveanu LB, Chiang VL, Kluger HM. Flanigan JC, et al. Among authors: jilaveanu lb. Clin Dermatol. 2013 May-Jun;31(3):264-81. doi: 10.1016/j.clindermatol.2012.08.008. Clin Dermatol. 2013. PMID: 23608446 Review.
Melanoma central nervous system metastases: current approaches, challenges, and opportunities.
Cohen JV, Tawbi H, Margolin KA, Amravadi R, Bosenberg M, Brastianos PK, Chiang VL, de Groot J, Glitza IC, Herlyn M, Holmen SL, Jilaveanu LB, Lassman A, Moschos S, Postow MA, Thomas R, Tsiouris JA, Wen P, White RM, Turnham T, Davies MA, Kluger HM. Cohen JV, et al. Among authors: jilaveanu lb. Pigment Cell Melanoma Res. 2016 Nov;29(6):627-642. doi: 10.1111/pcmr.12538. Epub 2016 Oct 22. Pigment Cell Melanoma Res. 2016. PMID: 27615400 Free PMC article. Review.
45 results